Analysis of antibody dynamics in Chinese children aged 1-3 years after single-dose varicella vaccination: A 42 months prospective study
Xiang Sun Lei Zhang Zhiguo Wang Wen Wang a Department of Expanded Program on Immunization,Jiangsu Provincial Center for Disease Control and Prevention,Nanjing,Jiangsu,Chinab Department of Rheumatology and Immunology,The Affiliated Suqian First People's Hospital of Nanjing Medical University,Suqian,Jiangsu,ChinaWang Wen a Deputy Chief Physician at the Department of Rheumatology and Immunology,the Affiliated Suqian First People's Hospital of Nanjing Medical University in Suqian,Jiangsu Province,China. My primary research interest lies in the prevention and treatment of vaccine-related diseases for special populations,such as diabetics,pregnant women,individuals with immunodeficiency,and healthcare workers. My work involves the study of various diseases including chickenpox,whooping cough,and shingles. My goal is to improve the health and well-being of these vulnerable groups through innovative immunization strategies and effective disease management.
DOI: https://doi.org/10.1080/21645515.2024.2410065
2024-10-16
Human Vaccines & Immunotherapeutics
Abstract:In China, children aged 12 months receive only a single dose of the varicella vaccine and the incidence of varicella remains high. This study aims to evaluate the changes in immunity among children aged 1–3 years following a single dose of the varicella vaccine, providing a scientific basis for determining the optimal age for a second vaccination. This prospective cohort study employed glycoprotein enzyme-linked immunosorbent assay (gpELISA) for antibody detection. The changes in IgG antibody levels over time post-vaccination were analyzed using a restricted cubic spline (RCS) fitted binary logistic regression model. Varicella surveillance data were collected from the National Notifiable Disease Reporting System (NNDRS). Following a peak in varicella incidence in 2019, the incidence shifted toward older age groups. The cohort study results revealed a seropositivity rate of 100% in children during the 18 months post-vaccination, which subsequently declined to 71.6% by the 42 months. The geometric mean concentration (GMC) decreased from 307.6mIU/mL to 115.2mIU/mL. Additionally, 14 children contracted varicella during the follow-up period, resulting in a breakthrough rate of 2.85%. RCS analysis indicated that antibody levels fell below the protective threshold 18.69 months post-vaccination, with a non-linear decline in the odds ratio(OR) of maintaining antibody concentrations ≥ 50mIU/mL( p < .001, Pnonlinear ≤ 0.001). This study demonstrates that the long-term protective efficacy of a single dose of the varicella vaccine diminishes over time in children, underscoring the necessity of implementing a two-dose vaccination strategy. The findings provide scientific evidence for determining the optimal timing for administering the second dose of the vaccine.
immunology,biotechnology & applied microbiology